Malignant Fallopian Tube Neoplasm — Trials

Malignant Fallopian Tube Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

744 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 168
Recruiting: 76
Ph III recruiting: 12
Growth YoY: +3.8%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02571725	PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer	active not recruiting	Phase 1 / Phase 2	50	New Mexico Cancer Research AllianceOTHER	1	May 23, 2025	clinicaltrials
NCT06846424	SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer	not yet recruiting	Phase 1	24	Shanghai Gynecologic Oncology GroupOTHER_GOV	1	Feb 26, 2025	clinicaltrials